Evaluation of two plasma‐based proteotyping assays against <i>APOE</i> ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies

Plasma-based proteotyping presented good to excellent sensitivity in identifying apolipoprotein E (APOE) ε4 homozygosity. The negative predictive value was also very good to excellent, allowing us to rule out APOE ε4 homozygosity with high precision. Assays with excellent precision show potential for identifying individuals for definitive APOE ε4 genotyping in a two-step approach.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-02-01
DOI
https://doi.org/10.1002/alz.14610
Citations
7
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
8.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of two plasma‐based proteotyping assays against APOE ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies

Nicholas James Ashton, Kaj Blennow, Andréa Lessa Benedet, Kina Höglund et al.
7 citations
Alzheimer s & Dementia
Alzheimer's disease research and treatments
8.15
article

Evaluation of two plasma‐based proteotyping assays against APOE ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies

Nicholas James Ashton, Kaj Blennow, Andréa Lessa Benedet, Kina Höglund, Ingmar Gr. Skoog, Anna Dittrich, Silke Kern, Henrik Zetterberg, Kübra Tan
article en
7 citations

Abstract

Plasma-based proteotyping presented good to excellent sensitivity in identifying apolipoprotein E (APOE) ε4 homozygosity. The negative predictive value was also very good to excellent, allowing us to rule out APOE ε4 homozygosity with high precision. Assays with excellent precision show potential for identifying individuals for definitive APOE ε4 genotyping in a two-step approach.

Alzheimer s & DementiaVol. 21(2)
University of Science and Technology of China (CN), University of Wisconsin–Madison (US), University of Arizona (US), Sahlgrenska University Hospital (SE), Sorbonne Université (FR), Region Västra Götaland (SE), Pitié-Salpêtrière Hospital (FR), UK Dementia Research Institute (GB), Banner Sun Health Research Institute (US), Institut du Cerveau (FR), University College London (GB), University of Gothenburg (SE)
Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Familjen Erling-Perssons Stiftelse, Cure Alzheimer's Fund, Stiftelsen för Gamla Tjänarinnor, EU Joint Programme – Neurodegenerative Disease Research, European Partnership on Metrology, National Institute for Health and Care Research, European Commission, Hjärnfonden, Vetenskapsrådet, Norges Forskningsråd, Sahlgrenska Universitetssjukhuset, Göteborgs Universitet, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, Forskningsrådet om Hälsa, Arbetsliv och Välfärd, Kirsten og Freddy Johansens Fond, Stiftelsen Psykiatriska Forskningsfonden, Alzheimerfonden, University College London Hospitals NHS Foundation Trust, UK Dementia Research Institute, Olav Thon Stiftelsen, Fondation pour la Recherche sur Alzheimer, Horizon 2020 Framework Programme, HORIZON EUROPE Framework Programme, UCLH Biomedical Research Centre, H2020 Marie Skłodowska-Curie Actions
Good health and well-being
Openalex Percentile: Top 3%
Alzheimer's disease research and treatments
8.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.